Commentary: "Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease" by Dankers M et al. in Frontiers in Pharmacology 2020; 10: 1519

Gardado en:

Detalles Bibliográficos
Main Authors:	Harma Alma (Author), Corina de Jong (Author), Janwillem Kocks (Author), Thys van der Molen (Author)
Formato:	Libro
Publicado:	Frontiers Media S.A., 2020-06-01T00:00:00Z.
Subjects:	article
Acceso en liña:	Connect to this object online.
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación:	A1234.567
Copia 1	Dispoñible